About Esken Pharmaceuticals Limited
Data last updated:
Esken Pharmaceuticals Limited is a public limited company based in Mehsana, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 July 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1992PLC017941. Its GSTIN is 24AAACE2637A1ZD (Gujarat).
The company has an authorised share capital of ₹6.3 Cr and a paid-up capital of ₹1.59 Cr. It is led by directors including Pranavkumar Manilal Patel (Whole-Time Director) and Ashishkumar Tribhovandas Patel (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 322 G I D C Phase Iidediasan Mehsana, Gujarat, India – 384001.
As per the financials filed for FY 2024, the company reported a revenue of ₹46.28 Lakh, a growth of 26% compared to the previous year. For the same year it recorded a net loss of ₹1.2 Lakh (net margin -2.6%) and EBITDA of -₹89,000 (EBITDA margin -1.9%). Revenue has declined at a compounded annual rate (CAGR) of 43% over three years and 11% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹2.84 Cr on record. Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eskenpharmaceuticals.com.
Company details
Contact details
Esken Pharmaceuticals Limited's registered office is in Mehsana, Gujarat. Its website is eskenpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address322 G I D C Phase Iidediasan Mehsana, Gujarat, India – 384001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Esken Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Esken Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Esken Pharmaceuticals Limited, buy the company report.
Financials of Esken Pharmaceuticals Limited
FY 2025 filings availableEsken Pharmaceuticals Limited reported revenue of ₹46.28 Lakh (up 26% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 26% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 11%. EBITDA rose 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹89,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.9% | ||||
| Net Profit Margin | -2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Esken Pharmaceuticals Limited, buy the company report.
Board of directors of Esken Pharmaceuticals Limited
Esken Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pranavkumar Manilal Patel Also directs: Spielberg Beverages Private Limited | Whole-Time Director | 06 Jul 1997 | 29 Years 3 Months | Current |
| Ashishkumar Tribhovandas Patel | Whole-Time Director | 06 Jul 1997 | 29 Years 3 Months | Current |
| Nigamkumar Babulal Patel | Whole-Time Director | 06 Jul 1997 | 29 Years 3 Months | Current |
Peer comparison
Esken Pharmaceuticals Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Esan Pharmaceuticals Private Limited | ₹46.41 Lakh (FY 2025) | -11.0% | New Delhi, Delhi, India | |||
| Prolific Labs Private Limited | ₹46.34 Lakh (FY 2024) | -16.0% | New Delhi, Delhi, India | |||
| Esken Pharmaceuticals Limitedthis company | ₹46.28 Lakh (FY 2024) | -₹1.2 Lakh | -2.6% | 26.0% | 3 | Mehsana, Gujarat, India |
| Chinubhai Pharma Pvt Ltd | ₹46.16 Lakh (FY 2025) | -38.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Esken Pharmaceuticals Limited, buy the company report.
Auditor
Esken Pharmaceuticals Limited is audited by H V DOSHI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H V DOSHI & CO | FY 2019 | 112353W |
Shareholding
The shareholding of Esken Pharmaceuticals Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Esken Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 May 2016 | 100028731 | Others | ₹2.25 Cr | Satisfied | |
| 26 Feb 2009 | 10147777 | The Co-Operative Bank of Mehsana Limited | ₹25 Lakh | Satisfied | |
| 05 Jul 2008 | 10112748 | The Co-Operative Bank of Mehsana Limited | ₹25 Lakh | Satisfied | |
| 11 Jun 2007 | 10057508 | The Co-Op Bank of Mehsana Ltd. | ₹9 Lakh | Satisfied |
To see the full charge records of Esken Pharmaceuticals Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Esken Pharmaceuticals Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mahesana, Gujarat | Criminal complaint | Filed against the company by Laxmark Pharma Suitical Pra.Lmt Director Kalpeshbhai Mahendrabhai Dave | Disposed |
| District court, Mahesana, Gujarat | Criminal complaint | Filed against the company by Leksmark Pharmaceuricals Limited | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by an individual | Disposed |
To see the full case history of Esken Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Esken Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Esken Pharmaceuticals Limited has a workforce of 3 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
GST
Esken Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACE2637A1ZD | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Esken Pharmaceuticals Limited, buy the company report.
Recent activity
Esken Pharmaceuticals Limited has 5 board changes on record since 1997: 3 appointments and 2 cessations. The latest: Bharatkumar Manilal Patel ceased to be Managing Director on 12 May 2015.
4 earlier events are in the company report.
Frequently asked questions
Esken Pharmaceuticals is an active public limited company based in Mehsana, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 July 1992 (34+ years old) and is registered under CIN U24231GJ1992PLC017941.
Esken Pharmaceuticals has 3 current directors:
- Pranavkumar Manilal Patel - Whole-Time Director
- Ashishkumar Tribhovandas Patel - Whole-Time Director
- Nigamkumar Babulal Patel - Whole-Time Director
The latest financial statements of Esken Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Esken Pharmaceuticals is 24AAACE2637A1ZD, registered in Gujarat.
The CIN (Corporate Identification Number) of Esken Pharmaceuticals is U24231GJ1992PLC017941. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Esken Pharmaceuticals has 3 court cases on record: 3 filed against it. Most are in the district courts.
Esken Pharmaceuticals was incorporated on 07 July 1992, making it 34+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Esken Pharmaceuticals by revenue are Esan Pharmaceuticals Private Limited, Prolific Labs Private Limited, Chinubhai Pharma Pvt Ltd, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bharatkumar Manilal Patel ceased to be Managing Director on 12 May 2015. Manilal Kashiram Patel ceased to be Director on 21 May 2010. Ashishkumar Tribhovandas Patel was appointed as Whole-Time Director on 06 Jul 1997. Esken Pharmaceuticals has 5 board changes on record in total.
Esken Pharmaceuticals can be reached through the website eskenpharmaceuticals.com. Its registered office is in Mehsana, Gujarat, India.
The registered office of Esken Pharmaceuticals is at 322 G I D C Phase Iidediasan Mehsana, Gujarat, India – 384001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
